Literature DB >> 2229056

Growth pattern of the murein sacculus of Escherichia coli.

B Glauner1, J V Höltje.   

Abstract

The mechanism by which the murein sacculus of Escherichia coli is being enlarged during growth was investigated by pulse and pulse-chase labeling with [3H]diaminopimelic acid. Changes in the composition of the sacculus during aging were analyzed in detail by high performance liquid chromatography separation of the muropeptide subunits released after complete muramidase digestion. After pulses as short as 10 s, a group of novel phosphorylated muropeptides was detected. The kinetics of their appearance is consistent with these structures being derived from the undecaprenylphosphate-linked growing points of murein. A complex maturation process of murein took place including a rapid decay of pentapeptide side chains and a 10-fold increase in tripeptidyl moieties. In addition, the total degree of cross-linkage increased from 16 to 25%, partly due to a 3-fold increase in the formation of LD-A2pm-A2pm cross-links. In pulse-chase experiments the cross-linkage started to decrease after a maximum at about 35 min of chase. The kinetics in the distribution of the radioactivity among acceptor and donor part in the major cross-bridges Tetra-Tetra and Tetra-Tri differed from each other substantially, indicating that the latter structure is completely cleaved within three generations, whereas only 40% of Tetra-Tetra is cleaved during the same time. Furthermore, the attachment of the lipoprotein to murein was delayed by about one generation. It is proposed that these findings reflect an inside-to-outside growth mechanism of the murein sacculus of E. coli.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229056

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Polarity in action: asymmetric protein localization in bacteria.

Authors:  S R Lybarger; J R Maddock
Journal:  J Bacteriol       Date:  2001-06       Impact factor: 3.490

2.  Tertiary structure of bacterial murein: the scaffold model.

Authors:  Boris A Dmitriev; Filip V Toukach; Klaus-Jürgen Schaper; Otto Holst; Ernst T Rietschel; Stefan Ehlers
Journal:  J Bacteriol       Date:  2003-06       Impact factor: 3.490

Review 3.  Bacterial wall as target for attack: past, present, and future research.

Authors:  Arthur L Koch
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

Review 4.  The architecture of the murein (peptidoglycan) in gram-negative bacteria: vertical scaffold or horizontal layer(s)?

Authors:  Waldemar Vollmer; Joachim-Volker Höltje
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

5.  Processivity of peptidoglycan synthesis provides a built-in mechanism for the robustness of straight-rod cell morphology.

Authors:  Oleksii Sliusarenko; Matthew T Cabeen; Charles W Wolgemuth; Christine Jacobs-Wagner; Thierry Emonet
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

6.  Elasticity of the sacculus of Escherichia coli.

Authors:  A L Koch; S Woeste
Journal:  J Bacteriol       Date:  1992-07       Impact factor: 3.490

7.  Cell shape and cell-wall organization in Gram-negative bacteria.

Authors:  Kerwyn Casey Huang; Ranjan Mukhopadhyay; Bingni Wen; Zemer Gitai; Ned S Wingreen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-02       Impact factor: 11.205

Review 8.  Synthesis of the cell surface during the division cycle of rod-shaped, gram-negative bacteria.

Authors:  S Cooper
Journal:  Microbiol Rev       Date:  1991-12

9.  Beta-lactam antibiotics induce a lethal malfunctioning of the bacterial cell wall synthesis machinery.

Authors:  Hongbaek Cho; Tsuyoshi Uehara; Thomas G Bernhardt
Journal:  Cell       Date:  2014-12-04       Impact factor: 41.582

10.  Murein-metabolizing enzymes from Escherichia coli: existence of a second lytic transglycosylase.

Authors:  H Engel; A J Smink; L van Wijngaarden; W Keck
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.